Delivery Order SPE2DR25D2014-SPE2DR26FA1J8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,352.04 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Yuvafem 10 MCG vaginal insert (18-count) under a firm fixed-price contract with a ceiling value of $1,240.42. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of January 5, 2026. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,803.36 delivery order on December 30, 2025, for Yuvafem 10 mcg vaginal inserts (18 units). This is a firm fixed-price, non-set-aside contract with a completion date of December 31, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.00 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,264.63 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (18-count package) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price contract was competitively awarded with no set-aside provisions and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $6,029.91 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order was placed under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.49 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count package) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $35,938.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1J8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,786.36 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 7, 2026, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including prescription medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The firm's substantial IDC demonstrates its established capability to efficiently fulfill federal medical supply requirements on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/5/26 |